Trials of various approaches to health insurance and other policy issues can help policymakers decide how to structure incentives to provide the best value. This review examines this type of trial, addressing issues common to and distinct from trials of drugs or devices.
No takes yet. Share an insight, caveat, or question.
Newhouse et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: